Chimeric antigen receptor modified T-cells for cancer treatment-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Chimeric antigen receptor modified T-cells for cancer treatment

Published:2018-12 Issue:4 Volume:4 Page:225-243
ISSN:2095-882X
Container-title:Chronic Diseases and Translational Medicine
language:en
Short-container-title:Chronic Diseases and Translational Medicine

Author:

Han Xiao,Wang Yao,Han Wei-Dong

Funder

the National Natural Science Foundation of China

the Science and Technology Planning Project of Beijing City

National Key Research and Development Program of China

Publisher

Elsevier BV

Subject

General Medicine

Reference131 articles.

1. New development in CAR-T cell therapy;Wang;J Hematol Oncol,2017

2. Expression of immunoglobulin-T-cell receptor chimeric molecules as functional receptors with antibody-type specificity;Gross;Proc Natl Acad Sci USA,1989

3. T cells engineered with a chimeric antigen receptor (CAR) targeting CD19 (CTL019) have long term persistence and induce durable remissions in children with relapsed, refractory ALL;Grupp;Blood,2014

4. Advances of CD19-directed chimeric antigen receptor-modified T cells in refractory/relapsed acute lymphoblastic leukemia;Wei;Exp Hematol Oncol,2017

5. Efficiency of CD19 chimeric antigen receptor-modified T cells for treatment of B cell malignancies in phase I clinical trials: a meta-analysis;Zhang;Oncotarget,2015

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting Tumors;Advances in Medical Diagnosis, Treatment, and Care;2024-08-28

2. Advancements and Challenges in Cancer Immunotherapy;Advances in Medical Diagnosis, Treatment, and Care;2024-08-28

3. Emerging Therapeutic Strategies to Overcome Drug Resistance in Cancer Cells;Cancers;2024-07-07

4. Therapeutic potential of CRISPR/CAS9 genome modification in T cell-based immunotherapy of cancer;Cytotherapy;2024-05

5. Current progress in chimeric antigen receptor-modified T cells for the treatment of metastatic breast cancer;Biomedicine & Pharmacotherapy;2023-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3